We are incredibly proud to announce that Alina Castell, CEO & Founder of MyCural Therapeutics, has been named “Årets Innovatör” (Innovator of the Year) by WiB Capital. 🏆
This prestigious award recognizes visionary leaders who are shaping the future through bold ideas, groundbreaking research, and a deep commitment to meaningful change. Alina’s work in advancing MYC-targeted therapies—an innovative approach with the potential to transform how we treat cancer—perfectly embodies the spirit of this recognition.
Under Alina’s leadership, MyCural Therapeutics has made significant strides in developing targeted cancer treatments designed to address one of the most challenging drivers of tumor growth. Her vision, scientific excellence, and passion for patient-centered innovation continue to inspire our team and fuel our mission to revolutionize cancer care.
We extend our heartfelt thanks to WiB Capital for this honor, and to all our supporters who believe in our work and our vision. This award is not just a personal milestone for Alina—it’s a celebration of the entire MyCural team and our shared dedication to improving lives through science and innovation.
Thank you for being part of our journey. The future of cancer therapy is being written today—and we’re just getting started.
